Retrospective Review of Iron Deficiency Profiles in Toddlers Presenting With Their First Febrile Seizure

Main Article Content

Muhammad Mohsin Shoukat
Azba Israr
Syed Hassan Tanvir Ramzi
Gulmakai Khilji
Samina Habib
Samia Shahid

Abstract

Background: Febrile seizures are common neurological events in early childhood, and iron deficiency has been proposed as a biologically plausible contributor to altered neuronal excitability because of its role in neurodevelopment, neurotransmitter synthesis, and cerebral energy metabolism. Objective: To determine whether iron deficiency profiles are associated with prolonged seizure duration among toddlers presenting with their first febrile seizure. Methods: This retrospective observational analytical study reviewed electronic medical records, archived laboratory reports, and paediatric emergency registers from tertiary care hospitals in Central Punjab for children aged 6–36 months presenting with first documented febrile seizure between January 2022 and December 2024. After exclusions, 132 eligible records were analyzed. Iron status was categorized as normal iron status, depleted iron stores, latent iron deficiency, or iron deficiency anemia using integrated hematological indices. Statistical analysis included descriptive statistics, chi-square testing, ANOVA, and binary logistic regression adjusted for age, sex, nutritional status, family history, and peak presenting temperature. Results: Depleted iron stores were identified in 42 children (31.8%), latent iron deficiency in 36 (27.3%), iron deficiency anemia in 29 (22.0%), and normal iron status in 25 (18.9%). Mean seizure duration increased progressively from 3.1 ± 1.2 minutes in children with normal iron status to 5.6 ± 2.0 minutes in those with iron deficiency anemia. Seizures lasting longer than five minutes increased from 12.0% to 48.3% across the same spectrum. Iron profile was significantly associated with prolonged seizure duration (χ² = 11.82; p = 0.008), with latent iron deficiency (adjusted OR = 2.18; 95% CI: 1.04–4.55; p = 0.038) and iron deficiency anemia (adjusted OR = 2.94; 95% CI: 1.31–6.58; p = 0.009) independently associated with higher odds of prolonged seizure. Conclusion: Worsening iron deficiency profiles were significantly associated with prolonged first febrile seizure duration in toddlers, suggesting that latent and overt iron deficiency may represent clinically relevant markers of greater seizure severity during febrile illness

Article Details

Section

Articles

How to Cite

1.
Muhammad Mohsin Shoukat, Azba Israr, Syed Hassan Tanvir Ramzi, Gulmakai Khilji, Samina Habib, Samia Shahid. Retrospective Review of Iron Deficiency Profiles in Toddlers Presenting With Their First Febrile Seizure. JHWCR [Internet]. 2026 May 18 [cited 2026 May 19];4(10):1-11. Available from: https://jhwcr.com/index.php/jhwcr/article/view/1642

References

1. Khan MS, Tarafder MMH. Exploring the association between pediatric iron deficiency anemia and febrile seizures: evidence from a tertiary care setting.

2. Sankar H, Shriram V, Elayaraja SJ. An analysis on role of iron deficiency in febrile seizure among children in 6 months to 5 years: a case-control study. J Fam Med Prim Care. 2024;13(12):5562-5569.

3. Anand S. A study on the relationship between iron deficiency anemia and febrile seizures. 2025.

4. Raavi DYC. A study on iron status in children presenting with febrile seizures of age group 6 months to 5 years. 2023.

5. Khan MAU, Rumi HM, Atina SAK, Tasdika TE, Tasnim N, Salauddin G. Association of simple febrile seizure with iron deficiency anemia in children in a tertiary hospital in Gazipur, Bangladesh. 2025:745-749.

6. Korczak A, Wójcik E, Olek E, Łopacińska O, Stańczyk K, Korn A, et al. The long-term effects of iron deficiency in early infancy on neurodevelopment. 2024;70:51104.

7. Leung AK, Lam JM, Wong AH, Hon KL, Li X. Iron deficiency anemia: an updated review. Curr Pediatr Rev. 2024;20(3):339-356.

8. Apu MAI, Halder D, Shuvo MS, Sarker MR. Iron deficiency in children can impair growth and contribute to anemia. Asian J Health Res. 2023;11:58-67.

9. Fioredda F, Skokowa J, Tamary H, Spanoudakis M, Farruggia P, Almeida A, et al. The European guidelines on diagnosis and management of neutropenia in adults and children: a consensus between the European Hematology Association and the EuNet-INNOCHRON COST action. 2023;7(4):e872.

10. Piccirillo A, Perri F, Vittori A, Ionna F, Sabbatino F, Ottaiano A, et al. Evaluating nutritional risk factors for delirium in intensive-care-unit patients: present insights and prospects for future research. 2023;13(6):1577-1592.

11. Pandey R, Pharasi N, Kaur P, Kaur L. Inborn errors of metabolism: from toxic, metabolic, and physical insults to neurodegenerative disorders. In: Evidence-Based Neurological Disorders. Jenny Stanford Publishing; 2024. p. 123-180.

12. Popa AE, Popa E, Dramba T, Coman EA, Poroch M, Ungureanu M, et al. Dysregulated resolution of inflammation after respiratory viral infections: molecular pathways linking neuroinflammation to post-viral neuropathic pain—a narrative review. 2025;26(23):11383.

13. Ashour WR, Ellakwa DE-S, Mostafa MM, Atiaa AG. Pharmacological and adjunctive therapies in neuroburn care. In: Burn-Induced Neurodegeneration. CRC Press; p. 217-242.

14. Sanders AE, Zafar N, Sharma S. Myoclonus. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2024.

15. Sonkar C, Chauhan S, Sonkar C. Perspective chapter: exploring cognitive impairment in long COVID—insights and therapeutic progress. In: Current Topics in Post-COVID Syndromes. IntechOpen; 2024.

16. Yi Y, Jia P, Xie P, Peng X, Zhu X, Yin S, et al. Beyond oxidative stress: ferroptosis as a novel orchestrator in neurodegenerative disorders. 2025;16:1683876.

17. Contreras-Puentes N, Castro-Leones M, Gutiérrez-Tovar B, Mendoza-Galiz J. Toxicity and allergies to medications. In: Allergies, Poisoning and Intolerance to Common Substances: Basic and Clinical Aspects. Springer; 2025. p. 95-133.

18. Lutsenko S, Roy S, Tsvetkov P. Mammalian copper homeostasis: physiological roles and molecular mechanisms. 2025;105(1):441-491.